# DRaCOon: a novel algorithm for pathway-level differential co-expression analysis in transcriptomics

**Authors:** Fernando M. Delgado-Chaves, Ferdinand Spurny, Tanja Laske, Mhaned Oubounyt, Jan Baumbach

PMC · DOI: 10.1186/s12859-025-06162-9 · BMC Bioinformatics · 2025-05-26

## TL;DR

DRaCOoN is a new tool for analyzing gene interactions in diseases, offering better insights into molecular changes for personalized medicine.

## Contribution

DRaCOoN introduces a novel permutation test and benchmarking framework for pathway-level differential co-expression analysis.

## Key findings

- DRaCOoN outperforms eight other methods in simulated and real-world datasets.
- The tool is robust to gene perturbation levels and identifies biologically relevant regulatory changes.
- It supports precision medicine by uncovering critical gene regulatory alterations.

## Abstract

Understanding the molecular mechanisms underlying diseases is crucial for more precise, personalized medicine. Pathway-level differential co-expression analysis, a powerful approach for transcriptomics, identifies condition-specific changes in gene-gene interaction networks, offering targeted insights. However, a key challenge is the lack of robust methods and benchmarks specifically for evaluating algorithms’ ability to identify disrupted gene-gene associations across conditions. We introduce DRaCOoN (Differential Regulatory and Co-expression Networks), a Python package and web tool for pathway-level differential co-expression analysis. DRaCOoN uniquely integrates multiple association and differential metrics, with a novel, computationally efficient permutation test for significance assessment. Crucially, DRaCOoN also provides a benchmarking framework for comprehensive method evaluation. Extensive benchmarking on simulated data and three real-world datasets (bone healing, colorectal cancer, and head/neck carcinoma) showed that DRaCOoN, particularly with an entropy-based association measure and the s differential metric, consistently outperforms eight other methods. It remains highly accurate in balanced datasets, robust to varying gene perturbation levels, and identifies biologically relevant regulatory changes. Furthermore, DRaCOoN serves as both a powerful tool and a benchmarking framework for elucidating disease mechanisms from transcriptomics data, advancing precision medicine by uncovering critical gene regulatory alterations.

## Linked entities

- **Diseases:** colorectal cancer (MONDO:0005575)

## Full-text entities

- **Diseases:** colorectal cancer (MESH:D015179), head/neck carcinoma (MESH:D006258)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12107744/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12107744/full.md

## References

2 references — full list in the complete paper: https://tomesphere.com/paper/PMC12107744/full.md

---
Source: https://tomesphere.com/paper/PMC12107744